Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

TAP and Gallus Co-host Free Webinar
Wednesday, October 01, 2014
Explaining the benefits of using ambr15 microbioreactors for DoE.

LINK Appoints New CEO
Tuesday, September 30, 2014
LINK has appointed Dr David Ricketts as its new Chief Executive Officer.

Gilead Announces Generic Licensing Agreements
Saturday, September 27, 2014
Indian companies granted license to produce generic sofosbuvir and investigational single tablet regimen of ledipasvir/sofosbuvir for treatment of chronic hepatitis C.

Adaptimmune Secures $104 Million in Series A Financing
Friday, September 26, 2014
Company will use funding to advance programmes in multiple cancer indications.

NIH Exceptional Responders to Cancer Therapy Study Launched
Friday, September 26, 2014
Study to investigate the molecular factors of tumors associated with exceptional treatment responses of cancer patients to drug therapies.

Catalent and Cingulate Therapeutics Sign Exclusive Agreement
Friday, September 26, 2014
Licensing agreement for development of new ADHD treatments.

Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax
Friday, September 26, 2014
Large scale manufacturing of BioThrax in Building 55 will increase annual production capacity from 7-9 million doses to a target of 20-25 million doses.

Avalon Ventures and GlaxoSmithKline Launch Two New Companies
Friday, September 26, 2014
Companies include Silarus Therapeutics developing treatments for anemia and iron overload disorders; and Thyritope Biosciences developing treatments for Graves’ orbitopathy.

PCI Announces Acquisition of Biotec
Friday, September 26, 2014
Acquisition expands clinical trial and cold chain services.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 3171
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv